Peer review and the process of publishing of adverse drug event reports

Area of Science:

• Medical Research Methodology
• Pharmacovigilance
• Scientific Publishing Ethics

Background:

• Many physicians complete careers without scientific publication.
• Published case reports, particularly on drug toxicity, often lack scientific rigor.
• These reports can be misleading and potentially harmful.

Purpose of the Study:

• To critically evaluate the scientific validity of medical case reports.
• To highlight the unreliability of case reports in assessing drug toxicity.
• To propose improvements in adverse event detection and reporting.

Main Methods:

• Analysis of the inherent limitations of retrospective, uncontrolled case reports.
• Examination of case reports as a form of hearsay evidence.
• Review of recent failures in the scientific publishing and peer review process.

Main Results:

• Case reports are frequently incomplete, lack operational criteria, and resemble hearsay.
• Reliance on journal integrity, authors, and peer review for validity is not always justified.
• Examples of process failures in publishing unreliable data are presented.

Conclusions:

• Medical case reports, especially concerning drug toxicity, are often methodologically flawed.
• The use of robust pharmacovigilance algorithms is recommended to improve the reliability of adverse event data.
• Enhancing the integrity of scientific publishing requires addressing the limitations of case report methodology.